April 1, 2025 - 17:27

A new joint venture has been established under the name WTL & MWP Investco, focusing on delivering growth capital to financial advice practices throughout Australia. This initiative marks a significant step in enhancing the financial advisory landscape, responding to the increasing demand for expert financial services in the region.
WTL & MWP Investco plans to empower financial advisors by providing the necessary resources to expand their operations and improve service offerings. The joint venture is poised to support a diverse range of advisory practices, enabling them to navigate the challenges of a rapidly evolving financial environment.
With a commitment to fostering innovation and growth, WTL & MWP Investco aims to create sustainable opportunities for financial advisors, ensuring they can better serve their clients. This collaboration represents a strategic move to strengthen the financial advice sector, ultimately benefiting consumers seeking reliable financial guidance in Australia.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...